These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18070680)

  • 21. Toxic epidermal necrolysis and Stevens-Johnson's disease.
    Ohlenschlaeger K
    Acta Derm Venereol; 1966; 46(2):204-9. PubMed ID: 4162642
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lyell and Stevens-Johnson syndromes. Apropos of 4 cases].
    Robineau M; Bisson M; Le Parco JC; Modai J; Domart A
    Lyon Med; 1971; 225():Suppl:113-9. PubMed ID: 5564790
    [No Abstract]   [Full Text] [Related]  

  • 23. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rash and fever.
    McCann DJ; Nadel ES; Brown DF
    J Emerg Med; 2006 Oct; 31(3):293-7. PubMed ID: 16982364
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxic epidermal necrolysis (Lyell syndrome).
    Bedi BM
    Lepr India; 1983 Oct; 55(4):780-1. PubMed ID: 6668936
    [No Abstract]   [Full Text] [Related]  

  • 27. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lyell's syndrome in drug disease].
    Sukhomlinov AB
    Feldsher Akush; 1982; 47(1):20-3. PubMed ID: 6916645
    [No Abstract]   [Full Text] [Related]  

  • 29. [Stevens-Johnson syndrome in a 3-year-old boy].
    Lipińska-Piotrowska I; Kaczorowska-Hanke H; Slowińska I
    Wiad Lek; 1973 Jun; 26(11):1059-62. PubMed ID: 4719927
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.
    Todd G
    Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic approach to drug allergy.
    Harr T
    Chem Immunol Allergy; 2012; 97():47-60. PubMed ID: 22613853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 33. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Koh MJ; Tay YK
    Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug eruptions in children.
    Shin HT; Chang MW
    Curr Probl Pediatr; 2001 Aug; 31(7):207-34. PubMed ID: 11500668
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the problem of vesicular dermatoses].
    Loban KM; Ryzhkov EV
    Sov Med; 1966 Jan; 29(1):135-9. PubMed ID: 5985153
    [No Abstract]   [Full Text] [Related]  

  • 39. [Side effects of drugs used in pediatric dermatology].
    Markova IV; Zver'kova FA
    Vestn Dermatol Venerol; 1984 Aug; (8):38-42. PubMed ID: 6385528
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
    Sotozono C; Ueta M; Kinoshita S
    Arch Dermatol; 2009 Nov; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.